Pnc Financial Services Group, Inc. Gritstone Bio, Inc. Transaction History

Pnc Financial Services Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$1.28 - $2.85 $12,727 - $28,337	-9,943 Reduced 99.43%	57 $0
Q2 2022 Aug 12, 2022	SELL	$1.77 - $4.34 $77 - $190	-44 Reduced 0.44%	10,000 $24,000
Q1 2022 May 12, 2022	BUY	$4.03 - $12.19 $40,300 - $121,900	10,000 Added 22727.27%	10,044 $41,000
Q1 2021 May 07, 2021	SELL	$4.07 - $27.11 $61 - $406	-15 Reduced 25.42%	44 $0
Q4 2020 Feb 12, 2021	BUY	$2.57 - $4.22 $151 - $248	59 New	59 $0

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.